Publication | Closed Access

The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis

Hematological MalignancyOncologyMedicineCell DeathT-leukemia/lymphoma Cells ApoptosisAnti-cancer AgentPharmacologyCell BiologyCancer Research